Literature DB >> 34559433

Tumor necrosis factor receptor-1 is selectively sequestered into Schwann cell extracellular vesicles where it functions as a TNFα decoy.

Mahrou Sadri1, Naoya Hirosawa1,2, Jasmine Le1,3, Haylie Romero1,4, Stefano Martellucci1, Hyo Jun Kwon1, Donald Pizzo5, Seiji Ohtori2, Steven L Gonias5, Wendy M Campana1,3,4.   

Abstract

Schwann cells (SCs) are known to produce extracellular vesicles (EV) that participate in cell-cell communication by transferring cargo to target cells, including mRNAs, microRNAs, and biologically active proteins. Herein, we report a novel mechanism whereby SC EVs may regulate PNS physiology, especially in injury, by controlling the activity of TNFα. SCs actively sequester tumor necrosis factor receptor-1 (TNFR1) into EVs at high density, accounting for about 2% of the total protein in SC EVs (~1000 copies TNFR1/EV). Although TNFR2 was robustly expressed by SCs in culture, TNFR2 was excluded from SC EVs. SC EV TNFR1 bound TNFα, decreasing the concentration of free TNFα available to bind to cells and thus served as a TNFα decoy. SC EV TNFR1 significantly inhibited TNFα-induced p38 MAPK phosphorylation in cultured SCs. When TNFR1 was proteolytically removed from SC EVs using tumor necrosis factor-α converting enzyme (TACE) or neutralized with antibody, the ability of TNFα to activate p38 MAPK in the presence of these EVs was restored. As further evidence of its decoy activity, SC EV TNFR1 modified TNFα activities in vitro including: (1) regulation of expression of other cytokines; (2) effects on SC morphology; and (3) effects on SC viability. SC EVs also modified the effects of TNFα on sciatic nerve morphology and neuropathic pain-related behavior in vivo. By sequestering TNFR1 in EVs, SCs may buffer against the potentially toxic effects of TNFα. SC EVs provide a novel mechanism for the spatial and temporal regulation of neuro-inflammation.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  Schwann cells; TNF Receptor-1; TNFα; extracellular vesicles; neuropathic pain; peripheral nerve injury

Mesh:

Substances:

Year:  2021        PMID: 34559433     DOI: 10.1002/glia.24098

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   8.073


  2 in total

1.  α1-Antitrypsin derived SP16 peptide demonstrates efficacy in rodent models of acute and neuropathic pain.

Authors:  Zixuan Wang; Stefano Martellucci; Alicia Van Enoo; Dana Austin; Cohava Gelber; Wendy M Campana
Journal:  FASEB J       Date:  2022-01       Impact factor: 5.834

2.  Schwann cell extracellular vesicles: judging a book by its cover.

Authors:  Steven L Gonias; Wendy M Campana
Journal:  Neural Regen Res       Date:  2023-02       Impact factor: 6.058

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.